LLLucas Vasconcelos Lima

Lucas Vasconcelos Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucas Vasconcelos Lima has a total of 110 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Erdosteine Provides Effective Analgesia in Inflammatory Pain Without Impairing Pain Resolution: A Preclinical Comparison With Non‐Steroidal Anti‐Inflammatory Drugs

    by Lucas Vasconcelos Lima, Mohamad Karaky, Grace Yu, Massimo Allegri, Nicoletta Marchesi, Stefano Govoni, Clive Page, Luda Diatchenko

    Background: Nonsteroidal anti‐inflammatory drugs (NSAIDs) provide effective analgesia but may paradoxically delay tissue recovery, pain resolution and contribute to chronic pain. Erdosteine, a thiol‐based prodrug with antioxidant and anti‐inflammatory properties, is a mucolytic used for treatment of respiratory diseases but has recently been suggested to possess analgesic potential. Methods: We examined the analgesic efficacy of erdosteine and its metabolite, Met‐1, in experimental models of inflammatory and neuropathic pain and compared its effects with diclofenac and gabapentin. Male mice received complete Freund's adjuvant (CFA) or chronic constriction injury (CCI) to induce inflammatory or neuropathic pain, respectively. Erdosteine (100 or 300 mg/kg, per os), its metabolite MET‐1 (intravenous), diclofenac (per os), gabapentin (per os), or vehicle (per os or intravenous as appropriate) were administered for 7 days following CFA or CCI. In separate experiments, treatments were initiated prior to CFA. Mechanical allodynia was quantified by von Frey testing. Plasma levels of CXCL1, S100A8/S100A9, IL‐1Ra, and 8‐isoprostane were measured by ELISA. Results: Erdosteine significantly reduced CFA‐induced allodynia, with efficacy comparable to diclofenac and gabapentin. Unlike diclofenac, erdosteine did not delay pain recovery in post‐CFA or pre‐CFA experimental settings and did not elevate plasma CXCL1 or 8‐isoprostane levels. Conclusions: Erdosteine provides robust analgesia in an experimental model of inflammatory pain without disrupting inflammation‐resolution pathways or increasing oxidative stress, supporting its potential as a safe, non‐opioid analgesic. These findings support further investigation of erdosteine as a potential, non‐opioid analgesic drug that does not produce the adverse events associated with NSAIDs. Perspective: Erdosteine produced NSAID‐comparable analgesia in inflammatory pain without delaying recovery or increasing oxidative and inflammatory markers. Given concerns that NSAIDs may prolong pain resolution, these findings identify erdosteine as a potential non‐opioid alternative that relieves inflammatory pain while preserving physiological healing processes. Significance Statement: Effective and well‐tolerated treatments for chronic pain remain limited. Erdosteine is a clinically approved mucolytic with antioxidant and anti‐inflammatory properties whose analgesic potential is largely unexplored. We show that oral erdosteine reduces inflammatory pain and allodynia without delaying recovery, unlike the NSAID diclofenac, which increased systemic markers of inflammation and prolonged pain duration. These findings identify erdosteine as a promising candidate for drug repurposing and support further investigation of its potential utility in pain management.

  • Effect of transcutaneous electrical nerve stimulation associated to exercise for pain in Parkinson’s disease: a randomized crossover clinical trial

    by P. A. Garcez, B. M DeJesus, L. R. Oliveira, L. V. Lima, J. M. DeSantana

    Parkinson's disease (PD) causes debilitating motor and non-motor symptoms, including chronic pain. While TENS and exercise are potential treatments, their combined effects require investigation. To assess the effect of TENS added to an exercise program on pain intensity (primary outcome), fatigue, temporal summation, pain catastrophizing, skin sensitivity, and depression in PD. This randomized, double-blind, crossover trial included 13 patients (Hoehn & Yahr II-III). Participants received active or placebo TENS (1:1 ratio) followed by the reverse order after a 7-day washout. Both phases included a 20-minute exercise program. Active TENS (100 Hz, 100 μs) was applied to thoracic and lumbar regions at motor threshold. Outcome assessors and participants were blinded to the intervention. All 13 participants completed both phases (n = 26). Compared to placebo, the active TENS group showed significant improvements in primary outcome of pain intensity (p = 0.006). Significant improvements were also observed in temporal summation (p = 0.004) and cutaneous sensibility (thoracic right (p = 0.002), left (p = 0.041). No adverse events were reported during the interventions. TENS combined with exercise is effective for reducing pain intensity, temporal summation, and fatigue, as well as improving cutaneous sensibility in patients with PD. ReBEC identifier is RBR-4bvwxq (UTN: U1111-1159-1101).

  • Open Access

    Olfactory exposure to late-pregnant and lactating mice causes stress-induced analgesia in male mice

    by Sarah F. Rosen, Lucas V. Lima, Civia Chen, Rachel Nejade, Mengyi Zhao, Wataru Nemoto, Ece Toprak, Aleksandrina Skvortsova, Shannon N. Tansley, Alicia Zumbusch, et al.

    In an attempt to improve reproducibility, more attention is being paid to potential sources of stress in the laboratory environment. Here, we report that the mere proximity of pregnant or lactating female mice causes olfactory-mediated stress-induced analgesia, to a variety of noxious stimuli, in gonadally intact male mice. We show that exposure to volatile compounds released in the urine of pregnant and lactating female mice can themselves produce stress and associated pain inhibition. This phenomenon, a novel form of female-to-male chemosignaling, is mediated by female scent marking of urinary volatiles, such as n -pentyl-acetate, and likely signals potential maternal aggression aimed at defending against infanticide by stranger males.


  • Top Cited Papers

    Acute inflammatory response via neutrophil activation protects against the development of chronic pain

    by Marc Parisien, Lucas V. Lima, Concetta Dagostino, Nehme El-Hachem, Gillian L. Drury, Audrey V. Grant, Jonathan Huising, Vivek Verma, Carolina B. Meloto, Jaqueline R. Silva, et al.

    The transition from acute to chronic pain is critically important but not well understood. Here, we investigated the pathophysiological mechanisms underlying the transition from acute to chronic low back pain (LBP) and performed transcriptome-wide analysis in peripheral immune cells of 98 participants with acute LBP, followed for 3 months. Transcriptomic changes were compared between patients whose LBP was resolved at 3 months with those whose LBP persisted. We found thousands of dynamic transcriptional changes over 3 months in LBP participants with resolved pain but none in those with persistent pain. Transient neutrophil-driven up-regulation of inflammatory responses was protective against the transition to chronic pain. In mouse pain assays, early treatment with a steroid or nonsteroidal anti-inflammatory drug (NSAID) also led to prolonged pain despite being analgesic in the short term; such a prolongation was not observed with other analgesics. Depletion of neutrophils delayed resolution of pain in mice, whereas peripheral injection of neutrophils themselves, or S100A8/A9 proteins normally released by neutrophils, prevented the development of long-lasting pain induced by an anti-inflammatory drug. Analysis of pain trajectories of human subjects reporting acute back pain in the UK Biobank identified elevated risk of pain persistence for subjects taking NSAIDs. Thus, despite analgesic efficacy at early time points, the management of acute inflammation may be counterproductive for long-term outcomes of LBP sufferers.


  • Open Access

    Long-term male-specific chronic pain via telomere- and p53‑mediated spinal cord cellular senescence

    by Arjun Muralidharan, Susana G. Sotocinal, Noosha Yousefpour, Nur Akkurt, Lucas V. Lima, Shannon Tansley, Marc Parisien, Chengyang Wang, Jean-Sebastien Austin, Boram Ham, et al.

    Mice with experimental nerve damage can display long‑lasting neuropathic pain behavior. We show here that 4 months and later after nerve injury, male but not female mice displayed telomere length (TL) reduction and p53‑mediated cellular senescence in the spinal cord, resulting in maintenance of pain and associated with decreased lifespan. Nerve injury increased the number of p53‑positive spinal cord neurons, astrocytes, and microglia, but only in microglia was the increase male‑specific, matching a robust sex specificity of TL reduction in this cell type, which has been previously implicated in male‑specific pain processing. Pain hypersensitivity was reversed by repeated intrathecal administration of a p53‑specific senolytic peptide, only in male mice and only many months after injury. Analysis of UK Biobank data revealed sex-specific relevance of this pathway in humans, featuring male‑specific genetic association of the human p53 locus (TP53) with chronic pain and a male-specific effect of chronic pain on mortality. Our findings demonstrate the existence of a biological mechanism maintaining pain behavior, at least in males, occurring much later than the time span of virtually all extant preclinical studies.


  • Open Access

    Mast cell stabilizer ketotifen fumarate reverses inflammatory but not neuropathic-induced mechanical pain in mice

    by Carolina B. Meloto, Pablo Ingelmo, Eduardo Vega Perez, Rebecca Pitt, Víctor Hugo González Cárdenas, Nada Mohamed, Susana G. Sotocinal, Valerie Bourassa, Lucas Vasconcelos Lima, Alfredo Ribeiro-Da-Silva, et al.

    Introduction: Mast cell (MC) activation could establish a positive feedback loop that perpetuates inflammation and maintains pain. Stabilizing MCs with ketotifen fumarate (KF) may disrupt this loop and relieve pain. Objective: We aimed to test the effect of treatment with KF in pain assays in mice and in a case series of patients with chronic widespread pain. Methods: The analgesic effect of KF was tested in CD-1 mice injected with formalin, complete Freund's adjuvant, or subjected to spared nerve injury. In addition, wild-type (C57BL/6) and MC-deficient (C57BL/6-Kit W-sh/W-sh) mice were injected with formalin or complete Freund's adjuvant and treated with KF. Patients with chronic widespread pain (n = 5; age: 13–16 years) who failed to respond to standard of care participated in a 16-week treatment trial with KF (6 mg/d). Ketotifen fumarate's therapeutic effect was evaluated using the patient global impression of change. Results: In the mouse experiments, KF produced dose- and MC-dependent analgesic effects against mechanical allodynia in the acute and chronic inflammatory pain but not neuropathic pain assays. In the patient case series, 4 patients reported that activity limitations, symptoms, emotions, and overall quality of life related to their pain condition were “better” or “a great deal better” since beginning treatment with KF. This was accompanied by improvements in pain comorbid symptoms. Conclusion: Treatment with KF is capable of reducing established inflammatory-induced mechanical nociception in an MC-dependent manner in mice, and it may be beneficial for the treatment of chronic pain conditions.


  • Immediate effects of transcutaneous electrical nerve stimulation (TENS) administered during resistance exercise on pain intensity and physical performance of healthy subjects: a randomized clinical trial

    by Mayara A. Menezes, Thaís A. B. Pereira, Leonardo M. Tavares, Belissa T. Q. Leite, Antônio G. R. Neto, Leury M. S. Chaves, Lucas V. Lima, Marzo E. Da Silva-Grigolleto, Josimari M. DeSantana

    Exercise-induced muscle pain is a self-limiting condition which impacts physical activity habits. Transcutaneous electrical nerve stimulation (TENS) promotes pain reduction and functional improvement in different pain conditions. We propose that applying TENS during exercise might reduce pain and improve physical performance. Thus, we aimed to investigate immediate effects of TENS applied during resistance exercise.


  • Open Access

    The hearing of rural workers exposed to noise and pesticides

    by Tereza R. R. Sena, Solano S. F. Dourado, Lucas V. Lima, Angelo R. Antoniolli

    In work environments, different physical and chemical agents that may pose a risk to workers' hearing health coexist. In this context, occupational hearing loss stands out. It has mostly been attributed to only noise exposure, although there are other agents, that is, pesticides that might contribute to occupational hearing loss. In this report, two cases will be presented that consider rural workers exposed to pesticides and intense noise generated by an adapted rudimentary vehicle. The noise measured in this vehicle was 88.3 dBA up to 93.4 dBA. Pure-tone audiometry, distortion product otoacoustic emissions, and high-frequency audiometry tests were performed. This report is unusual because of the short time of exposure to noise and pesticides and the hearing loss found, indicating a synergy between those agents.


  • Short-duration physical activity prevents the development of activity-induced hyperalgesia through opioid and serotoninergic mechanisms

    by Lucas V. Lima, Josimari M. DeSantana, Lynn A. Rasmussen, Kathleen A. Sluka

    Regular physical activity prevents the development of chronic muscle pain through the modulation of central mechanisms that involve rostral ventromedial medulla (RVM). We tested if pharmacological blockade or genetic deletion of mu-opioid receptors in physically active mice modulates excitatory and inhibitory systems in the RVM in an activity-induced hyperalgesia model. We examined response frequency to mechanical stimulation of the paw, muscle withdrawal thresholds, and expression of phosphorylation of the NR1 subunit of the N-methyl-D-aspartate receptor (p-NR1) and serotonin transporter (SERT) in the RVM. Mice that had performed 5 days of voluntary wheel running prior to the induction of the model were compared with sedentary mice. Sedentary mice showed significant increases in mechanical paw withdrawal frequency and a reduction in muscle withdrawal threshold; wheel running prevented the increase in paw withdrawal frequency. Naloxone-treated and MOR−/− mice had increases in withdrawal frequency that were significantly greater than that in physically active control mice and similar to sedentary mice. Immunohistochemistry in the RVM showed increases in p-NR1 and SERT expression in sedentary mice 24 hours after the induction of the model. Wheel running prevented the increase in SERT, but not p-NR1. Physically active, naloxone-treated, and MOR−/− mice showed significant increases in SERT immunoreactivity when compared with wild-type physically active control mice. Blockade of SERT in the RVM in sedentary mice reversed the activity-induced hyperalgesia of the paw and muscle. These results suggest that analgesia induced by 5 days of wheel running is mediated by mu-opioid receptors through the modulation of SERT, but not p-NR1, in RVM.


  • Top Cited Papers

    Does exercise increase or decrease pain? Central mechanisms underlying these two phenomena

    by Lucas V. Lima, Thiago S. S. Abner, Kathleen A. Sluka

    Exercise is an integral part of the rehabilitation of patients suffering a variety of chronic musculoskeletal conditions, such as fibromyalgia, chronic low back pain and myofascial pain. Regular physical activity is recommended for treatment of chronic pain and its effectiveness has been established in clinical trials for people with a variety of pain conditions. However, exercise can also increase pain making participation in rehabilitation challenging for the person with pain. Animal models of exercise‐induced pain have been developed and point to central mechanisms underlying this phenomena, such as increased activation of NMDA receptors in pain‐modulating areas. Meanwhile, a variety of basic science studies testing different exercise protocols, show exercise‐induced analgesia involves activation of central inhibitory pathways. Opioid, serotonin and NMDA mechanisms acting in rostral ventromedial medulla promote analgesia associated with exercise. This review explores and discusses current evidence on central mechanisms underlying exercised‐induced pain and analgesia. image